Skip to main content

MILLENNIUM MANAGEMENT LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1273087 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$14,669,735
-$2,814,011 QoQ
Shares Held
3,281,820
+3.2% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Derivatives in TSHA

reported options exposure · as of Sep 30, 2025
CallValue
$1,266,798
CallShares
387,400
PutValue
$719,400
PutShares
220,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. TSHA ranks #77 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,669,735 3,281,820
2025-12-31 $17,483,746 3,178,863
2025-09-30 $719,400 220,000
2025-09-30 $13,165,418 4,026,122
2025-09-30 $1,266,798 387,400
2025-06-30 $6,781,531 2,935,728
2025-03-31 $2,463,989 1,772,654
2024-12-31 $262,292 151,614
2024-06-30 $763,221 340,724
2024-03-31 $430,500 150,000
2024-03-31 $8,998,359 3,135,317
2023-12-31 $88,500 50,000
2023-12-31 $5,983,541 3,380,532
2023-09-30 $158,000 50,000
2023-06-30 $406,474 614,938
2023-03-31 $380,681 477,045
2022-12-31 $873,691 386,589
2022-09-30 $336,549 174,378
2022-06-30 $804,144 216,168
2021-12-31 $699,570 60,049
2021-06-30 $639,498 30,165
2021-03-31 $428,837 21,125
2020-12-31 $514,876 19,400
2020-09-30 $3,880,956 173,257